PEY17 COST-EFFECTIVENESS OF PEGAPTANIB IN AGE-RELATED MACULAR DEGENERATION- IMPACT OF DIFFERENCES BETWEEN US AND UK HEALTH CARE SYSTEMS
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63723-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)63723-0/fulltext
Title :
PEY17 COST-EFFECTIVENESS OF PEGAPTANIB IN AGE-RELATED MACULAR DEGENERATION- IMPACT OF DIFFERENCES BETWEEN US AND UK HEALTH CARE SYSTEMS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63723-0&doi=10.1016/S1098-3015(10)63723-0
First page :
Section Title :
Open access? :
No
Section Order :
572